title: Genetic resistance of mice to Mycobacterium paratuberculosis is influenced by Slc11a1 at the early but not at the late stage of infection.
abstract: We have recently described the development of a luminescent Mycobacterium paratuberculosis strain of bovine origin expressing the luxAB genes of Vibrio harveyi. With this luminescent isolate, fastidious and costly enumeration of CFU by plating them on agar can be replaced by easy and rapid luminometry. Here, we have reevaluated the effect of Slc11a1 (formerly Nramp1) polymorphism on susceptibility to M. paratuberculosis, using this luminometric method. A series of inbred mouse strains were infected intravenously with luminescent M. paratuberculosis S-23 and monitored for bacterial replication in spleen, liver, and lungs for 12 weeks. The results indicate that, as for Mycobacterium avium subsp. avium, innate resistance to infection is genetically controlled by Slc11a1. In BALB/c, congenic BALB.B10-H2(b) (BALB/c background; H-2(b)), C57BL/6, and beige C57BL/6(bg/)(bg) mice (all Slc11a1(s)), bacterial numbers in spleen and liver remained unchanged during the first 4 weeks of infection, whereas in DBA/2 and congenic BALB/c.DBA/2 (C.D2) mice (both Slc11a1(r)) and in (C57BL/6 x DBA/2)F(1) mice (Slc11a1(s/r)), the bacterial numbers had decreased more than 10-fold at 4 weeks postinfection in both male and female mice. At later time points, additional differences in bacterial replication were observed between the susceptible mouse strains, particularly in the liver. Whereas bacterial numbers in the liver gradually decreased more than 100-fold in C57BL/6 mice between week 4 and week 12, bacterial numbers were stable in livers from BALB/c and beige C57BL/6(bg/)(bg) mice during this period. Mycobacterium-specific gamma interferon responses developed earlier and to a higher magnitude in C57BL/6 mice than in BALB/c mice and were lowest in resistant C.D2 mice.
authors.affiliation: Mycobacterial Immunology, WIV-Pasteur Institute, 642 Engelandstraat, B1180 Brussels, Belgium.
authors.forename: Virginie
authors.initials: V
authors.lastname: Roupie
authors.forename: Valérie
authors.initials: V
authors.lastname: Rosseels
authors.forename: Virginie
authors.initials: V
authors.lastname: Piersoel
authors.forename: Denise K
authors.initials: DK
authors.lastname: Zinniel
authors.forename: Raúl G
authors.initials: RG
authors.lastname: Barletta
authors.forename: Kris
authors.initials: K
authors.lastname: Huygen
mesh_terms: D000818:Animals; D027682:Cation Transport Proteins / Q000235:genetics* / Q000276:immunology*; D015169:Colony Count, Microbial / Q000379:methods; D005260:Female; D017930:Genes, Reporter; D007113:Immunity, Innate; D007371:Interferon-gamma / Q000096:biosynthesis; D008099:Liver / Q000382:microbiology; D008164:Luminescent Proteins / Q000032:analysis / Q000235:genetics; D008168:Lung / Q000382:microbiology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D016927:Mycobacterium avium subsp. paratuberculosis / Q000235:genetics / Q000254:growth & development / Q000276:immunology* / Q000302:isolation & purification; D010283:Paratuberculosis / Q000276:immunology*; D011110:Polymorphism, Genetic; D013154:Spleen / Q000382:microbiology; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors; D000099173:Natural Resistance-associated Macrophage Protein 1
chemical_list: D027682:Cation Transport Proteins; D007371:Interferon-gamma; D008164:Luminescent Proteins; D000099173:Natural Resistance-associated Macrophage Protein 1